Muscular dystrophies are a group of diseases that are caused by a genetic mutation (a change in genetic material that can be passed on to children), affect muscles, and are progressive (increase in severity over time). The most common types are
Duchenne muscular dystrophy, the most common childhood form of muscular dystrophy. It is an X-linked disease, which means that the gene is passed from mothers to their sons.
Becker muscular dystrophy, with a genetic defect very similar to that in Duchenne muscular dystrophy, but not as severe. Together, Duchenne and Becker muscular dystrophies affect 1 to 2 in 10 000 males between the ages of 5 and 24 years.
Myotonic dystrophy. Patients have myotonia (delayed relaxation of muscles after contraction), for example, after grasping a doorknob. There are several different types within this group. They occur in both men and women and affect about 1 in 8000 people. The December 14, 2011, issue of JAMA includes an article about myotonic muscular dystrophy.
The physical examination and personal history for each type of muscular dystrophy is different and contributes to the diagnosis.
In Duchenne muscular dystrophy, young boys start walking very late and have difficulties arising from the floor (Gowers sign, using their hands to push on their legs to get up). Intellectual impairment may also be present.
In Becker muscular dystrophy, weakness may be limited to the quadriceps (muscles in the front of the thigh).
Infants with type 1 myotonic dystrophy can have severe trouble breathing and swallowing and may not survive the neonatal (newborn) period. Adults with type 1 myotonic dystrophy may develop cataracts, hand and lower leg weakness and wasting (loss of muscle mass), and grip myotonia. Adults with later-onset type 2 myotonic dystrophy can have stiffness and myotonia in the thighs and hands, neck weakness, and hip weakness with trouble climbing stairs.
The blood level of creatine kinase (a protein released with muscle breakdown) is abnormally high early in Duchenne muscular dystrophy. As the disease progresses and muscle mass decreases, the level of creatine kinase decreases.
Blood tests look for the genetic mutations that cause each type of muscular dystrophy. These allow a definitive diagnosis.
Muscular dystrophies are progressive diseases. Children with Duchenne muscular dystrophy often require a wheelchair by their teenage years, as do children with Becker muscular dystrophy in their late adolescence.
Because muscular dystrophies affect muscles everywhere in the body, including the lungs and heart, patients may need specialized care, such as a pacemaker. Each of the forms has unique features that require attention. For example, myotonic dystrophy can lead to impotence and high cholesterol levels.
Corticosteroids may improve muscle strength and function in Duchenne dystrophy. In patients with myotonic dystrophy, other medications improve myotonia. However, muscular dystrophies cannot be cured and weakness is progressive. Many people with either Duchenne or Becker muscular dystrophy may die in their early to late 20s.
Mayo Clinic www.mayoclinic.com/health/muscular-dystrophy/DS00200
Genetics Home Reference ghr.nlm.nih.gov/condition/myotonic-dystrophyghr.nlm.nih.gov/condition/duchenne-and-becker-muscular-dystrophy
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at www.jama.com. Many are available in English and in Spanish.
Sources: Mayo Clinic, Genetics Home Reference, Centers for Disease Control and Prevention
Topic: MUSCULOSKELETAL SYNDROMES
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.
Punnoose AR, Burke AE, Golub RM. Muscular Dystrophy. JAMA. 2011;306(22):2526. doi:10.1001/jama.2011.1794